Development and Evaluation of Live Biotherapeutic Product in the form of Mucoadhesive Vaginal Tablets containing living Lactobacillus spp.
Ars Pharmaceutica (Internet) · 20.06.2026 · 67 (3) · 316-327
DOI: 10.30827/ars.v67i3.36176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 20.06.2026. Verfasst von Aleksandar Aleksovski und 2 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to develop and evaluate mucoadhesive vaginal tablets containing viable Lactobacillus spp., with a focus on the impact of formulation composition and processing parameters on product properties and performance.
Methods
Powder blends were prepared by mixing and compressed into tablets using an eccentric single-punch press. Powder flow, water activity, residual moisture, tablet physicochemical properties, swelling capacity, mucoadhesive retention time, and detachment force were evaluated. Lactobacillus viability in the drug substance complex (DSC), blends, and tablets was assessed by CFU counting in De Man–Rogosa–Sharpe (MRS) broth and simulated vaginal fluid (SVF).
Results
Formulations based on chitosan–carbomer and chitosan–carbomer–polyethylene oxide (PEO) showed the longest and most reproducible mucoadhesive retention (up to 8 h). Despite acceptable indirect flow indices, both blends exhibited poor to very poor powder flow. The ternary polymer formulation produced more uniform and mechanically robust tablets, attributed to the plastic deformation and compressibility of PEO. Chitosan–carbomer tablets showed pronounced swelling due to strong polyelectrolyte complex formation, while inclusion of PEO moderated swelling and resulted in higher, more stable detachment forces. Viability remained high in DSC and blends but decreased after compression. No viable bacteria were detected in SVF, likely due to chitosan antimicrobial activity at acidic pH and/or bacterial entrapment within a dense polymer matrix.
Conclusions
Chitosan-carbomer and chitosan-carbomer-PEO based mucoadhesive vaginal tablets show promise for vaginal delivery of live bacteria, though challenges related to powder flow, compression-induced viability loss, and lack of survival in SVF require further optimization.
Zitieren
APA
Aleksovski, A., Hosseini, H., & Alkhafaji, H. (2026). Development and Evaluation of Live Biotherapeutic Product in the form of Mucoadhesive Vaginal Tablets containing living Lactobacillus spp. Ars Pharmaceutica (Internet), 67(3), 316-327. https://doi.org/10.30827/ars.v67i3.36176
Vancouver
Aleksovski A, Hosseini H, Alkhafaji H. Development and Evaluation of Live Biotherapeutic Product in the form of Mucoadhesive Vaginal Tablets containing living Lactobacillus spp. Ars Pharmaceutica (Internet). 2026;67(3):316-327. doi:10.30827/ars.v67i3.36176
BibTeX
@article{Aleksovski2026,
author = {Aleksovski, Aleksandar and Hosseini, Haniehsadat and Alkhafaji, Hajar},
title = {Development and Evaluation of Live Biotherapeutic Product in the form of Mucoadhesive Vaginal Tablets containing living Lactobacillus spp},
journal = {Ars Pharmaceutica (Internet)},
year = {2026},
volume = {67},
number = {3},
pages = {316--327},
doi = {10.30827/ars.v67i3.36176}
}
EUVIMED